Top compounds associated with response to PRKAR2A


Feature Type Standardized
Nominal ANOVA
mRNA CUDC-101 GDSC1000 pan-cancer AAC -0.12 0.0001
mRNA nelarabine CTRPv2 pan-cancer AAC -0.15 0.0001
mRNA barasertib CTRPv2 pan-cancer AAC -0.13 0.0002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA VX-680 GDSC1000 pan-cancer AAC -0.19 0.0002
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.12 0.0003
mRNA LAQ824 GDSC1000 pan-cancer AAC -0.12 0.0004
mRNA OSU-03012 GDSC1000 pan-cancer AAC -0.12 0.0004
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
Download CSV